Delivery Order SPE2DB22D2206-SPE2DB25FDS37
Award Date
10/9/24
Potential Completion Date
10/10/24
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $3,772.27 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,322,209 units of the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,247.86, is for the supply of the drug Cefepime-Dextrose 2 GM/50 MLS. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,821.52, is for the provision of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product. The contract has an ultimate completion date of May 17, 2023 and is a Firm Fixed Price type contract. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,681.34 fixed-price delivery order is for the supply of Cefepime-Dextrose 2 GM/50 ML, a specialty medication, with a performance period through January 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,072,289 units of the pharmaceutical product Cefepime-Dextrose 2 gm/50 mL. The delivery order, valued at $3,653.65, has an ultimate completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,241.14 firm fixed-price delivery order is for the supply of the injectable medication Cefepime-Dextrose 2 GM/50 MLS. The contract has a completion date of December 12, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,023.24, is a delivery order for the supply of 4563866018 - CEFEPIME-DEXTROSE 2 GM/50 MLS, with a performance period ending on March 6, 2024. The contract is a firm fixed-price agreement and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $14,903.68 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 4564015152 CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,419.23, is for the delivery of 4563336197 CEFEPIME-DEXTROSE 2 GM/50 MLS medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of January 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of the pharmaceutical product Cefepime-Dextrose 2 GM/50 MLS. The $2,571.96 firm-fixed-price delivery order has a completion date of June 14, 2022. This contract is not designated as a set-aside. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...